心脏手术患者的冲击阶段:心脏切除术后冲击和死亡率的影响
Nicolas Brozzi1, Federico Napoli1, Rene Aleman1
1Department of Cardio-Thoracic Surgery at Heart, Thoracic & Vascular Institute at Cleveland Clinic Florida, Weston, Florida, USA.
JACC. Advances
|July 11, 2025
概括
CS-SCAI分期系统有效预测心脏手术患者的死亡风险. 手术后的CS-SCAI阶段恶化显著增加了30天的死亡率,突出了其预后价值.
科学领域:
- 心血管外科心血管外科
- 关键护理医学 关键护理医学
- 健康 结果 研究 研究 结果
背景情况:
- 准确的风险预后对于识别心脏手术后死亡风险高的患者至关重要.
- 心血管造影与干预学会 (SCAI) 的冲击构造为评估冲击严重程度提供了一个框架.
研究的目的:
- 为心脏手术患者适应SCAI冲击结构,创建CS-SCAI分期系统.
- 评估CS-SCAI分期在不同时间点与心脏手术后患者存活率的相关性.
主要方法:
- 胸腔外科医生协会成人心脏手术数据库的回顾性分析 (2015年1月 - 2019年12月).
- 利用多变量物流分析来检查影响30天生存的因素.
- 根据临床参数定义的CS-SCAI阶段AE,包括心力衰竭,紧急手术,复苏,血管活性使用和机械支持.
主要成果:
- 包括1,164,015名患者;手术前的CS-SCAI阶段A-E显示死亡率从1.2%增加到42.1%.
- CS-SCAI阶段是术前和术后死亡率的最强预测因素.
- 6,508名患者在术后过渡到更糟糕的CS-SCAI阶段,30天死亡率为51.6%. 预测因素包括绕道时间,手术前阶段和十字时间.
结论:
- CS-SCAI分期系统有效地促进了心脏手术前后的风险预后.
- 阶段过渡与高死亡率的频谱有关,并可以完善心脏切除术后休克的定义.
相关概念视频
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
29
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
29
01:24Blood Pressure Imbalances and Circulatory Shock
1.0K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.0K
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
80
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
80
01:22Aneurysm IV: Nursing Management
22
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
22
01:28Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
01:28Cardiac Catheterization I: Pre-Procedure Overview
167
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
167